Immunovia with acting CEOImmunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated. more ➔
Onxeo with interim CEO Paris-based Onxeo S.A. has started the new year with an interim CEO. Julien Miara has taken over the position. more ➔
Successor wanted Gabriella Björknert Caracciolo will leave Bactiguard AB, where she currently works as CFO and deputy CEO. more ➔
Back as CEO Swedish Oncopeptides has had a new CEO since mid-November. Jakob Lindberg has taken over the position from Marty J. Duvall again. He has left the company. more ➔
Immunovia in search of a new CEO Lund-based Immunovia will need a new CEO, because Patrik Dahlen wants to leave the diagnostics company for personal reasons. more ➔
Genoskin appointed CSO Dr Nicolas Gaudenzio has been started at the beginning of November as Chief Scientific Officer of Genoskin. more ➔
From interim to permanent Lotta Ferm, interim CFO of Immunicum AB, was now named as Chief Financial Officer. more ➔
BIAL with new R&D General Manager BIAL, a public limited company under Portuguese law with head office in Coronado, Portugal, appointed Joerg Holenz as R&D General Manager and as a member of the Board of Directors. more ➔
Mogrify strengthens leadership team Cambridge-based Mogrify Limited announced the appointment of Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. more ➔
New CSO for Cellbox Solutions Since October, Dr. Gisèle Deblandre has strengthened the team of Cellbox Solutions GmbH in Norderstedt near Hamburg as Chief Scientific Officer. more ➔